|Articles|November 1, 2022
Supplements and Featured Publications
- Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
- Volume 28
- Issue 12
eAppendix: Provider and Patient Knowledge Gaps on Biosimilars: Insights From Surveys
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders
3
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
4
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
5












































